Close Menu

NEW YORK — Biological Dynamics said on Thursday that it has received roughly $1 million in new funding from the Bill and Melinda Gates Foundation to support the continued development of a tuberculosis (TB) detection assay.

The test is based on the same alternating current electrokinetic technology underlying the firm's Verita lab-on-a-chip platform, using an alternating current to create a non-uniform electric field that can capture particles within particular size ranges while repelling those that are smaller or larger.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.